![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H32N6 |
Molar mass | 452.606 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Tribendimidine is a broad-spectrum anthelmintic agent developed in China, at the National Institute of Parasitic DiseasesinShanghai. It is a derivative of amidantel.[1]
Inclinical trials, it was highly effective in treating ankylostomiasis, ascariasis and enterobiasis.[2] It is also effective against clonorchiasis.[3] However, animal studies suggest it is ineffective in treating Schistosoma mansoniorFasciola hepatica disease.[1] The drug has also performed well in trials against opisthorchiasis, curing about 70% of cases.[4]
Tribendimidine is manufactured by Shandong Xinhua Pharmaceutical Company LimitedinZibo, Shandong, China. It was approved by the China Food and Drug Administration in 2007.[citation needed]
| |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiplatyhelmintic agents |
| ||||||||||||||
Antinematodal agents (including macrofilaricides) |
| ||||||||||||||
|
![]() | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |